TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
IDL Biotech AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
43,550
|
34,807
|
22,330 |
Financial expenses |
14
|
6
|
2 |
Earnings before taxes |
-4,862
|
236
|
-12,421 |
EBITDA |
-3,756
|
3,108
|
-12,002 |
Total assets |
34,187
|
38,064
|
40,290 |
Current assets |
26,758
|
31,295
|
34,313 |
Current liabilities |
8,181
|
9,243
|
5,945 |
Equity capital |
25,911
|
28,734
|
34,257 |
- share capital |
25,554
|
23,860
|
24,599 |
Employees (average) |
23
|
20
|
16 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
75.8%
|
75.5%
|
85.0% |
Turnover per employee |
1,893
|
1,740
|
1,396 |
Profit as a percentage of turnover |
-11.2%
|
0.7%
|
-55.6% |
Return on assets (ROA) |
-14.2%
|
0.6%
|
-30.8% |
Current ratio |
327.1%
|
338.6%
|
577.2% |
Return on equity (ROE) |
-18.8%
|
0.8%
|
-36.3% |
Change turnover |
6,274
|
13,148
|
1,121 |
Change turnover % |
17%
|
61% | |
Chg. No. of employees |
3
|
4
|
-2 |
Chg. No. of employees % |
15%
|
25% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.